So RJS, how is it possible the EVH/NGIO can get quoted in the same article as the CEO of GSK, as well as being in an article mentioning the work of Pfizer, GSK, J&J and Sanofi, and yet we are trading at $.50?

Something is either very wrong or very foul in Denmark.

Deep breaths - if it's meant to be it will happen. Easy to type, not so easy to live through.